Medical Weight Loss for Kalispell, Montana Residents

Kalispell, Montana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Kalispell through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Follow-up that stays with you in Kalispell: your care does not end at the first visit, Dr. Sharma and our team check in by secure video as you progress, no matter where you are in Montana. Results vary. Doctor review just $119 (medication separate).

Why Kalispell Residents Choose New Hope Weight Loss

Continuity is the quiet advantage Kalispell patients notice most. Because Dr. Anjmun Sharma oversees your case throughout, the person adjusting your dose in month three is the same physician who reviewed you in week one. Nothing gets lost in a handoff. That consistency, delivered by telehealth from our Costa Mesa clinic, is what turns a prescription into actual ongoing care for people all over Montana.

If you are searching for medical weight loss in Kalispell, New Hope Weight Loss treats patients statewide by telehealth from our Costa Mesa, California clinic. Dr. Sharma reviews your history by secure video and, if appropriate, prescribes compounded semaglutide or tirzepatide shipped to you.

Telehealth is what lets us care for Kalispell, Montana from a single office in Costa Mesa, so you get Dr. Sharma's full attention without rearranging your day around an appointment across town. We care for patients throughout the greater Kalispell area and the Flathead Valley. Wherever you live in Montana, your medication ships straight to your door in discreet packaging, so the same care reaches you whether you are in Kalispell proper or one of the surrounding the greater Kalispell area and the Flathead Valley.

A patient in the busiest part of Kalispell and one in a quiet Montana suburb pay exactly the same: $119 for the physician review and semaglutide from $166 per month. We accept HSA and FSA cards for the $119 physician review, which lets many Kalispell patients use pre-tax dollars toward their care. In a state as wide-open as Montana, New Hope Weight Loss cares for patients entirely by telehealth from our Costa Mesa, California clinic, so distance is never a barrier to care.

GLP-1 Weight Loss Programs Available

Which GLP-1 program is right for you?

Our 90-Day Metabolic Reset runs on semaglutide, the same active ingredient as Wegovy and Ozempic. It starts at $166 a month, or $499 for 90 days, and branded-drug trials reported average loss near 15 to 17 percent. Because compounded semaglutide is not FDA-approved or brand-identical, results vary. Dr. Sharma guides every Kalispell patient by telehealth.

And if you want more horsepower

Tirzepatide, from $233 a month, adds GIP to the usual GLP-1 action. In branded-drug trials, dose-qualified participants reached up to 22.5 percent loss, which is not the typical outcome. It shares its active ingredient with Mounjaro and Zepbound.

A $119 physician review starts the process. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Kalispell

Starting care with us looks nothing like a traditional doctor visit. There is no office to find and no drive across Kalispell. You complete an online intake quiz covering your health background and weight goals, and Dr. Anjmun Sharma reviews it personally. She then meets you by secure video, typically within 48 hours, to decide together whether compounded semaglutide or tirzepatide is appropriate. If it is, a state-licensed 503(a) pharmacy ships your medication to your Kalispell address in cold-pack packaging that protects it in transit, and all of your follow-ups happen by video so your plan keeps moving wherever you are in .

Frequently Asked Questions, Kalispell

Does New Hope Weight Loss have a presence in Kalispell?

Our presence in Kalispell is through telehealth rather than a storefront. The clinic itself is in Costa Mesa, California, our sole physical location. We serve Kalispell, Montana patients online, and Dr. Anjmun Sharma confirms your eligibility for compounded semaglutide or tirzepatide during a private video consultation.

Could a Kalispell patient complete care without leaving home?

Yes, staying home is the norm. Everything for Kalispell patients runs over telehealth, including the initial consult, dose adjustments, and check-ins. After approval, your medication travels to Kalispell in insulated cold-pack shipping that protects it from temperature swings during delivery.

How are Kalispell patients charged?

There is a $119 fee for the physician review. Semaglutide starts at $166 monthly, with a 90-day option at $499, and tirzepatide at $233 monthly. The medication itself is a separate cost. We accept HSA, FSA, Klarna, and Affirm, and we add no distance surcharge for Kalispell.

What areas of Kalispell do you serve?

We serve patients from across Kalispell by telehealth, including the greater Kalispell area and the Flathead Valley.

Who qualifies for the program in Kalispell?

Eligibility for Kalispell patients is decided by Dr. Sharma during the medical review, based on your health history, current medications, and goals. The $119 visit is not charged if you are not a candidate, and there is no obligation to continue.

Kalispell Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Kalispell, Montana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.